After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NYSE listed company, CRL falls under the Healthcare sector while operating within the Diagnostics & Research industry segment. The current market capitalization of Charles River Laboratories International Inc is $8.25B. A total of 1.33 million shares were traded on the day, compared to an average of 999.18K shares.
In the most recent transaction, Joseph LaPlume bought 400 shares of CRL for 152.50 per share on Aug 22 ’25. In a previous transaction on Aug 18 ’25, LaPlume Joseph W sold 800 shares at 157.60 per share. CRL shares that EVP, Corp Strategy & Develop owns now total 24,116.
Among the insiders who bought shares, WALLMAN RICHARD F acquired of 22,500 shares on Aug 18 ’25 at a per-share price of $152.00. In another insider transaction, Joseph LaPlume bought 800 shares at $157.00 per share on Aug 18 ’25.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CRL has a high of $203.01 and a low of $91.86.
As of this writing, CRL has an earnings estimate of $2.34 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of $2.44 per share and a lower estimate of $2.25. The company reported an EPS of $2.66 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CRL’s latest balance sheet shows that the firm has $241.21M in Cash & Short Term Investments as of fiscal 2021. There were $2.92B in debt and $1.03B in liabilities at the time. Its Book Value Per Share was $69.20, while its Total Shareholder’s Equity was $2.59B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRL is Buy with a score of 4.25.
